Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Non Operating Income (2022 - 2025)

CervoMed's Non Operating Income history spans 9 years, with the latest figure at $317560.0 for Q3 2025.

  • For Q3 2025, Non Operating Income fell 75.96% year-over-year to $317560.0; the TTM value through Sep 2025 reached -$318239.0, down 124.48%, while the annual FY2024 figure was -$991.0, 100.02% down from the prior year.
  • Non Operating Income for Q3 2025 was $317560.0 at CervoMed, down from $357871.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $4.8 million in Q3 2023 and bottomed at -$2.5 million in Q4 2022.
  • The 4-year median for Non Operating Income is $80603.0 (2024), against an average of $304335.0.
  • The largest annual shift saw Non Operating Income skyrocketed 5483612.5% in 2023 before it tumbled 1283.46% in 2024.
  • A 4-year view of Non Operating Income shows it stood at -$2.5 million in 2022, then surged by 95.94% to -$101378.0 in 2023, then crashed by 1283.46% to -$1.4 million in 2024, then soared by 122.64% to $317560.0 in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Non Operating Income are $317560.0 (Q3 2025), $357871.0 (Q2 2025), and $408850.0 (Q1 2025).